Eris Lifesciences Share Price
1317.70+14.20 (+1.09%)
-25.97% past 1 Year
News
Eris Lifesciences to meet analysts and investors on August 27
Equity
ERIS
Eris Lifesciences Q1 EBITDA margin below long-term FY27 guidance range
Equity
ERIS
Eris Lifesciences Q1 revenue grows 13 percent, below FY27 guidance pace
Equity
ERIS
Eris Lifesciences Q1 FY earnings show EBITDA growth but margin compression
Equity
ERIS
Eris Lifesciences reports strong Q1 revenue growth on year-over-year basis
Equity
ERIS
Eris Lifesciences Q1 consolidated net profit rises 16.7 percent year-on-year
Equity
ERIS
Eris Lifesciences sets ambitious FY27 revenue growth and margin targets
Equity
ERIS
Eris Lifesciences - Quaterly Results
Equity
ERIS
Eris Lifescience guides FY27 revenue growth at 18 to 20 percent
Equity
ERIS
Eris Lifesciences issues FY27 revenue growth guidance of 18-20 percent
Equity
ERIS
Eris Lifesciences reports Profit after tax of Rs -8.60 Crores, in the March 2026 quarter
Equity
ERIS
Eris Lifesciences Q4 FY26 EBITDA grows with marginal improvement in margins
Equity
ERIS
Eris Lifesciences posts year-on-year revenue growth in Q4 earnings update
Equity
ERIS
Eris Lifesciences Q4 consolidated net profit surges sharply year-on-year
Equity
ERIS
Eris Lifesciences informs about allotment of equity shares
Equity
ERIS
Eris Lifesciences informs about newspaper publication
Equity
ERIS
Macquarie Retains Outperform on Eris Lifesciences with Rs 1,680 Target Post Halmed GMP Inspection.
Equity
ERIS
Macquarie Flags Unresolved Observations Slowing Eris Lifesciences CDMO Progress
Equity
ERIS
Eris Lifesciences Faces Halmed Inspection Flags on Swiss Units for Non-Compliance.
Equity
ERIS
Eris Lifesciences Ltd. NSE Block Trade of Rs 22.35 Crores for 152,561 Shares at Rs 1465.
Equity
ERIS